![[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease](/media/k2/items/cache/b7776ccd86677e084c73066d56234a62_L.jpg)
[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease
Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial – medRxiv
The post [Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease appeared first on Links Medicus.
-
Taille de police
Réduire la taille de la police
Augmenter la taille de police
About Author
Dernier de Zouhair Souissi
- Non-inferiority RCT: Reduced-Dose vs Full-Dose Direct Oral Anticoagulants for Extended VTE Treatment
- Systematic Review: Shorter Antibiotic Courses Often Prove Non-Inferior for Common Bacterial Infections
- Network Meta-analysis: Oseltamivir Fails to Improve Key Outcomes in Nonsevere Influenza
- Multidrug-resistant Gram-negative bacterial infections: Key Updates and Practical Strategies
- Introducing Our Free WhatsApp Channels for Daily Internal Medicine Articles!